Results 1 to 10 of about 19,651 (255)

O33 Qualitative story completion: an innovative method with exciting potential for health research [PDF]

open access: bronzeOral presentations, 2019
Background Story completion asks the participant to produce a story, in response to an open, sometimes ambiguous, scenario. As a method for qualitative research, it is relatively unknown. Yet the method has deep roots, with origins in psychotherapy practice (projective techniques, such as Rorschach) and (quantitative) developmental psychology research
Virginia Braun   +2 more
semanticscholar   +3 more sources

Microbial oil production from carbohydrates using Sporobolomyces carnicolor strain O33 [PDF]

open access: goldAnnals of Microbiology, 2011
A Sporobolomyces spp. (strain O33) was isolated from soil as a potential resource for producing microbial oil from carbohydrates. This microbe produced intracellular lipids from various carbohydrates, such as hexose, pentose, and polysaccharides. Major fatty acids found in the lipids were C18:1 (36–55%), C16:0 (18–29%), and C18:2 (15–28%), and these ...
Toru Matsui, Ken-ya Otsuka, Seigo Sato
semanticscholar   +4 more sources

One‐Pot Synthesis of a Tetrasaccharide Repeating Unit of O‐Antigen from Escherichia Coli O33 [PDF]

open access: bronzeAnnalen der Pharmacie
A tetrasaccharide repeating unit of the O‐antigen from Escherichia coli O33 has been synthesized for the first time using a chemoselective [1+1+2] one‐pot glycan assembly strategy.
Ao Sun   +8 more
openalex   +2 more sources

O33 TREATMENT OF INCARCERATED GROIN HERNIA - EMERGING EVIDENCE BASED ON THE SWEDISH HERNIA REGISTER [PDF]

open access: bronzeBritish Journal of Surgery, 2021
Abstract Aim The evidence base for statements about risk factors, morbidity and mortality for emergency hernia repair is mostly low quality. The aim of this study is to elucidate risk factors for the development of incarcerated hernia and outcome after adult emergency hernia repair using data from the
Hans Lederhuber   +2 more
openaire   +2 more sources

O33 Baricitinib in the BSRBR-RA registry: characteristics and status of patients at first follow-up [PDF]

open access: yesRheumatology, 2021
Abstract Background/Aims  Baricitinib is a once-daily orally administered Janus kinase (JAK)-inhibitor approved for the treatment of moderate-to-severe active rheumatoid arthritis (RA). The British Society for Rheumatology Biologics Registry-RA (BSRBR-RA) captures real-world data on biologic (b) and targeted synthetic (ts)
Christopher J Edwards   +6 more
openaire   +2 more sources

O33 Risk of Polymyalgic-Onset Inflammatory Arthritis in Patients Initially Diagnosed with Polymyalgia Rheumatica [PDF]

open access: bronzeRheumatology, 2016
Background: Previous studies from secondary care have suggested that inflammatory arthritis develops in up to 20.2% of patients with PMR within 12 months of disease onset. However, many cases of PMR are exclusively managed in the community and the true risk of subsequent inflammatory arthritis is unknown. This study aimed to determine the rate at which
Max Yates   +6 more
openaire   +2 more sources

O33: PROSPECTIVE RISK ASSESSMENT ALONE DOES NOT IMPROVE 30-DAY MORTALITY IN EMERGENCY LAPAROTOMY PATIENTS [PDF]

open access: bronzeBritish Journal of Surgery, 2021
Abstract Introduction Emergency laparotomy still carries a high mortality risk. According to the latest National Emergency Laparotomy Audit (NELA) report, half of the patients without pre-operative risk scoring had a higher observed than predicted mortality.
S Vavilov, P Pockney
openaire   +2 more sources

O33 Towards personalised weaning of sedatives and analgesics using mechanism-based modelling of iatrogenic withdrawal in critically ill children [PDF]

open access: bronzeArchives of Disease in Childhood, 2019
Background Prolonged treatment with analgesics and sedatives can result in iatrogenic withdrawal syndrome (IWS) in children being weaned from these drugs.1Personalized weaning strategies might lower the incidence of IWS, but this requires a quantitative ...
Sebastiaan C. Goulooze   +6 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy